319 related articles for article (PubMed ID: 21361889)
1. Bayesian design of noninferiority trials for medical devices using historical data.
Chen MH; Ibrahim JG; Lam P; Yu A; Zhang Y
Biometrics; 2011 Sep; 67(3):1163-70. PubMed ID: 21361889
[TBL] [Abstract][Full Text] [Related]
2. Bayesian Design of Non-Inferiority Clinical Trials via the Bayes Factor.
Li W; Chen MH; Wangy X; Dey DK
Stat Biosci; 2018 Aug; 10(2):439-459. PubMed ID: 30344778
[TBL] [Abstract][Full Text] [Related]
3. Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes.
Ibrahim JG; Chen MH; Xia HA; Liu T
Biometrics; 2012 Jun; 68(2):578-86. PubMed ID: 21955084
[TBL] [Abstract][Full Text] [Related]
4. Bayesian clinical trial design using historical data that inform the treatment effect.
Psioda MA; Ibrahim JG
Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
[TBL] [Abstract][Full Text] [Related]
5. Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome.
Chen MH; Ibrahim JG; Zeng D; Hu K; Jia C
Biometrics; 2014 Dec; 70(4):1003-13. PubMed ID: 25041037
[TBL] [Abstract][Full Text] [Related]
6. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
7. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
Doi M; Takahashi F; Kawasaki Y
Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
[TBL] [Abstract][Full Text] [Related]
8. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
Liu GF
Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
[TBL] [Abstract][Full Text] [Related]
9. Quantification of prior impact in terms of effective current sample size.
Wiesenfarth M; Calderazzo S
Biometrics; 2020 Mar; 76(1):326-336. PubMed ID: 31364156
[TBL] [Abstract][Full Text] [Related]
10. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
Feißt M; Krisam J; Kieser M
Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
[TBL] [Abstract][Full Text] [Related]
11. Bayesian hierarchical functional data analysis via contaminated informative priors.
Scarpa B; Dunson DB
Biometrics; 2009 Sep; 65(3):772-80. PubMed ID: 19173703
[TBL] [Abstract][Full Text] [Related]
12. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
13. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.
Lee SY
BMC Med Res Methodol; 2024 May; 24(1):110. PubMed ID: 38714936
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of stochastic engineering models as prior information in Bayesian medical device trials.
Haddad T; Himes A; Thompson L; Irony T; Nair R;
J Biopharm Stat; 2017; 27(6):1089-1103. PubMed ID: 28281931
[TBL] [Abstract][Full Text] [Related]
15. The scale transformed power prior for use with historical data from a different outcome model.
Alt EM; Nifong B; Chen X; Psioda MA; Ibrahim JG
Stat Med; 2023 Jan; 42(1):1-14. PubMed ID: 36318875
[TBL] [Abstract][Full Text] [Related]
16. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
17. Modified power prior with multiple historical trials for binary endpoints.
Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
[TBL] [Abstract][Full Text] [Related]
18. Power priors based on multiple historical studies for binary outcomes.
Gravestock I; Held L
Biom J; 2019 Sep; 61(5):1201-1218. PubMed ID: 30325059
[TBL] [Abstract][Full Text] [Related]
19. Bayesian designs and the control of frequentist characteristics: a practical solution.
Ventz S; Trippa L
Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
[TBL] [Abstract][Full Text] [Related]
20. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
